Skip to Main Content

Paper Details

Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients.
Sci Immunol
571
2020
COVID-19, IgA, IgG, IgG antibodies, IgM, IgM antibodies, SARS, SARS-CoV, SARS-CoV-2, SARS-CoV-2 spike antigens, SARS-CoV-2 spike protein, anti-SARS-CoV-2 IgA, patients, saliva IgG antibodies, serum IgG
Author NameAffiliation
Jeffrey L WranaLunenfeld-Tanenbaum Research Institute at Mount Sinai Hospital
Jeffrey L WranaUniversity of Toronto
Mario A OstrowskiUniversity of Toronto
Mario A OstrowskiUniversity of Toronto
Mario A OstrowskiSt. Michael's Hospital, Canada Li Ka Shing Knowledge Institute.
Anne-Claude GingrasLunenfeld-Tanenbaum Research Institute at Mount Sinai Hospital
Anne-Claude GingrasUniversity of Toronto
  • 1 - 7

Datasets

Release 1.2